DeepScribe
Oncology practices and specialty groups
DeepScribe works best for oncology practices and specialty groups. DeepScribe started as a general ambient scribe and has sharpened into the specialty play, most visibly in oncology. It says it reaches about 90% of community oncology centers and 40% of all US cancer visits, and embeds straight inside OncoEMR and iKnowMed. Points against: Oncology-first positioning may limit appeal for general practices. For everyday use, the company cites a 98.8 overall performance score in a 2025 KLAS spotlight report. From a buyer's view, oncology notes involve longitudinal complexity, staging, regimens, and prior authorizations that general-purpose scribes flatten. DeepScribe's customization studio and context-aware notes are designed for that. DeepScribe shows no starting price here, so confirm the cost on the vendor site. DeepScribe does not include a free plan.
Free plan: No
Website: deepscribe.ai
Strengths
- Embedded in OncoEMR and iKnowMed
- Specialty-tuned for oncology with pre-visit SmartPrep and automatic coding
Watch out for
- Enterprise pricing